Rockwell Medical Inc
RMTI0.998USD
+0.042+4.38%
交易中 （美東）報價延遲15分鐘
34.18M總市值
虧損本益比TTM
關於 Rockwell Medical Inc 公司
Rockwell Medical, Inc. 是一家醫療保健公司。該公司爲世界各地的透析提供商開發、製造、銷售和分銷一系列血液透析產品。該公司在血液透析市場開展業務，涉及製造、銷售和分銷血液透析產品給血液透析診所，包括透析過程中使用的藥品、透析濃縮液、透析套件和其他輔助產品。該公司是透析診所維持生命的血液透析濃縮液產品的供應商。其血液透析濃縮液產品用於通過清除毒素和平衡透析患者血液中的電解質來維持患者的生命。該公司在密歇根州、南卡羅來納州和德克薩斯州的工廠生產血液透析濃縮液，並在愛荷華州的工廠生產幹酸濃縮液混合器。
公司簡介
公司代碼RMTI
公司名稱Rockwell Medical Inc
上市日期Jan 27, 1998
CEODr. Mark Strobeck, Ph.D.
員工數量244
證券類型Ordinary Share
年結日Jan 27
公司地址30142 Wixom Road
城市WIXOM
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編48393
電話18004493353
網址https://www.rockwellmed.com/
公司代碼RMTI
上市日期Jan 27, 1998
CEODr. Mark Strobeck, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
290.62K
-2.33%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+52.38%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Director
Independent Director
142.06K
+54.31%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
130.99K
-2.14%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
106.84K
-0.82%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Senior Vice President, Chief Corporate Affairs Officer
Senior Vice President, Chief Corporate Affairs Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
290.62K
-2.33%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+52.38%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Director
Independent Director
142.06K
+54.31%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
130.99K
-2.14%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Concentrate Products
18.59M
98.28%
Drug Products
325.00K
1.72%
地區USD
名稱
營收
佔比
United States
16.44M
86.90%
Rest of World
2.48M
13.10%
業務
地區
業務USD
名稱
營收
佔比
Concentrate Products
18.59M
98.28%
Drug Products
325.00K
1.72%
股東統計
更新時間: 5月25日 週日
更新時間: 5月25日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Irrevocable Larson Family Investment Trust
10.41%
Armistice Capital LLC
6.92%
The Vanguard Group, Inc.
3.53%
GlobeFlex Capital, L.P.
2.17%
Renaissance Technologies LLC
1.33%
Other
75.64%
持股股東
持股股東
佔比
Irrevocable Larson Family Investment Trust
10.41%
Armistice Capital LLC
6.92%
The Vanguard Group, Inc.
3.53%
GlobeFlex Capital, L.P.
2.17%
Renaissance Technologies LLC
1.33%
Other
75.64%
股東類型
持股股東
佔比
Corporation
10.41%
Hedge Fund
8.67%
Investment Advisor
7.72%
Individual Investor
4.42%
Investment Advisor/Hedge Fund
3.56%
Research Firm
0.77%
Pension Fund
0.05%
Other
64.41%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
115
12.12M
35.46%
-1.47M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
2023Q3
122
6.04M
24.13%
+2.56M
2023Q2
133
3.92M
24.44%
+947.21K
2023Q1
150
2.67M
21.21%
-974.16K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Irrevocable Larson Family Investment Trust
3.56M
10.41%
+87.50K
+2.52%
Apr 11, 2025
Armistice Capital LLC
2.37M
6.92%
-677.53K
-22.26%
Mar 31, 2025
The Vanguard Group, Inc.
1.21M
3.53%
+1.50K
+0.12%
Mar 31, 2025
GlobeFlex Capital, L.P.
743.26K
2.17%
--
--
Mar 31, 2025
Renaissance Technologies LLC
453.00K
1.33%
+10.65K
+2.41%
Mar 31, 2025
Marshall Wace LLP
333.60K
0.98%
-262.76K
-44.06%
Mar 31, 2025
Geode Capital Management, L.L.C.
324.54K
0.95%
+4.12K
+1.29%
Mar 31, 2025
Strobeck (Mark)
297.55K
0.87%
+220.00K
+283.70%
May 20, 2025
BlackRock Institutional Trust Company, N.A.
215.67K
0.63%
-4.13K
-1.88%
Mar 31, 2025
Morgan Stanley & Co. LLC
164.10K
0.48%
+69.13K
+72.79%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
佔比0.01%
Dimensional US Core Equity 1 ETF
佔比0%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
May 12, 2022
Merger
11<1
May 12, 2022
Merger
11<1
May 12, 2022
Merger
11<1
May 12, 2022
Merger
11<1
公告日期
類型
比率
May 12, 2022
Merger
11<1
May 12, 2022
Merger
11<1
May 12, 2022
Merger
11<1
May 12, 2022
Merger
11<1
